key: cord-0893703-94rcg1l5
authors: Rajan, Mariappan; Gupta, Prashant; Kumar, Awanish
title: Promising Antiviral Molecules from Ayurvedic Herbs and Spices against COVID-19
date: 2021-02-05
journal: Chin J Integr Med
DOI: 10.1007/s11655-021-3331-8
sha: ff3d38b886dfb654abb73d1d659c3041ebe96a1d
doc_id: 893703
cord_uid: 94rcg1l5

nan

COVID-19 is caused by the novel coronavirus severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and smashed our society severely. Many efforts/measures have been taken worldwide to control coronavirus disease 2019 (COVID-19) but it is spreading ceaselessly across the globe. (1) Interestingly, Chinese medicine was used to treat COVID-19 and they found better recovery results. (2, 3) This has also drawn the attention of the scientifi c community to Ayurveda where traditional knowledge of this domain can be explored for fi nding COVID-19 a cure or prevention.

This technical note provides a first-round result that has been done at the interface of Ayurveda and in silico biology regarding COVID-19. This article aims to provide the readers an understanding of the basic principles of ancient medicine and conjugation of in silico technology in Ayurveda for the development of core concepts of Ayurveda. Quick screening of traditional herbs/spices phytoconstituents can be done by in silico study in polyherbal/Ayurvedic formulations. This inhibition/induction of phytoconstituents with target protein can quickly be identified by in silico study. (4, 5) Therefore, the authors have selected 11 herbs (Allium sativum, Cinnamomum cassia, Cuminum cyminum, Piper nigrum, Curcuma longa, Ocimum sanctum, Zingiber officinale, Coriandrum sativum, Syzygium aromaticum, Trachyaspermum ammi, Mentha arvensis) advised commonly in Ayurveda for in silico screening as an antimicrobial agent ( interface of Ayurveda and in silico biology. The reported result in this article (Table 1) is an Ayurveda phytoconstituents in silico efforts study which further necessitates the need for pre-clinical and clinical research of the active compounds ( Figure 1 ) to increase the understanding in the development of effective future therapeutics in Ayurveda.

None. 

Identifi cation of novel inhibitors of angiotensin-converting enzyme 2 (ACE-2) receptor from Urtica dioica to combat coronavirus disease 2019 (COVID-19)

Refl ections on treatment of COVID-19 with traditional Chinese medicine

Exploring an integrative therapy for treating COVID-19: a randomized controlled trial

The in silico drug discovery toolbox: applications in lead discovery and optimization

Spices chemoconstituents as persuasive inhibitor of S. typhimurium virulent protein L-asparaginase

COVID-19: targeting proteases in viral invasion and host immune response

Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor

Herbs and spices-biomarkers of intake based on human intervention studies-a systematic review